U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Nonprescription Drugs - Division of Nonprescription Drugs I
  1. CDER Offices and Divisions

Office of Nonprescription Drugs - Division of Nonprescription Drugs I

The Division of Nonprescription Drugs (DNPD I) regulates and reviews nonprescription products for:

  • Anesthesiology, Addiction Medicine, and Pain Medicine
  • Dermatology
  • Gastroenterology
  • Neurology
  • Pulmonary, Allergy and Critical Care
  • Psychiatry

Director: Nushin Todd, M.D.
Deputy Director: Martha Lenhart, M.D.

Deputy Director for Safety: Dorothy Chang, M.D.

Regulatory Operations
Chief of Project Management: Dan Brum, PharmD, MBA, BCPS 

Office Organization

Contact Us

Mailing Address: 

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Nonprescription Drugs
10903 New Hampshire Avenue WO22 Stop 5411
Silver Spring, MD 20993
301-796-0138



Back to Top